“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...
The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could ...
Health on MSN20h
How Much Longer Do We Have to Wait for a Norovirus Vaccine?Despite millions of cases of norovirus in the U.S. each year—and a current surge in outbreaks—there is still no vaccine for ...
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
Zacks.com on MSN2d
Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Stocktwits on MSN1d
Moderna Stock Tumbles After Best Day In 7 Months, But Retail Confidence Holds FirmShares of Moderna Inc. fell over 8% on Wednesday afternoon, paring some of the gains from Tuesday, the stock’s best trading ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback